Drug targeting Huntington’s disease–causing protein undergoing clinical trial

A drug that was found to have no dose-limiting side effects in nonhuman primates is being evaluated in a clinical trial for its ability to reduce production of the protein that causes Huntington’s...
Source: Clinical Neurology News - Category: Neurology Source Type: news